This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

IQVIA moves for judgment on US trade secret claims against Veeva

( October 22, 2024, 14:20 GMT | Official Statement) -- MLex Summary: IQVIA asked a US federal judge to enter a judgment in its favor on claims that Veeva Systems engaged in corporate theft and mishandling of confidential and proprietary information. “Having no honest path to build overnight what it had taken IQVIA decades (and hundreds of millions of dollars) to build, Veeva resorted to theft. As detailed below, Veeva bought a cheap, low-quality healthcare dataset from another company (AdvantageMS) and then proceeded to use IQVIA’s offerings to turn that low-quality dataset into a commercially viable one. Through years of rampant misappropriation from IQVIA, Veeva took an unlawful shortcut to success,” it said.See document below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections